#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Enteritis Marginal zone lymphoma Congenital pseudarthrosis Raynaud's phenomenon Ewing's sarcoma recurrent Metachromatic leukodystrophy Vascular calcification Adenocarcinoma pancreas Meningitis meningococcal Ovarian cancer B-cell small lymphocytic lymphoma refractory Haemophilia A with anti factor VIII Anti-myelin-associated glycoprotein associated polyneuropathy Chorioretinitis Primary myelofibrosis More trials…

    Learn about Rare Diseases

    Sjogren’s syndrome – Treatment Chronic granulomatous disease – Diagnostics Primary mediastinal large B-cell lymphoma – Treatment Waldenstrom’s macroglobulinaemia – Diagnostics Phenylketonuria – Trials in Disease Angiosarcoma metastatic Brain stem glioma – Treatment Synovial sarcoma metastatic – Treatment Sarcoma – Basic Information Angiosarcoma metastatic – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Terbinafine Hydrochloride Gindameran Avelumab ABBV-8736 Mitapivat Zoledronic Acid Linerixibat Lysine Hydrochloride Dorocubicel POTASSIUM HYDROXIDE Abc-23B-116 Moxifloxacin Datopotamab Deruxtecan Cannabidiol INOBRODIB Inupadenant Hydrochloride Water For Injection Mva-209-Fsp-B1 Pimecrolimus Risedronate Sodium More therapies…

    Learn about Your Condition

    Vaginal haemorrhage Dry mouth Anorexia nervosa Type 1 diabetes mellitus Gastrectomy Chronic sinusitis Obliterative bronchiolitis Dystonic tremor Genitourinary tract neoplasm End stage renal disease Appendicitis perforated Peripheral artery thrombosis Underweight Palpitations Congenital myopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of INBRX-109 with Irinotecan Hydrochloride Trihydrate and Temozolomide for Patients with Advanced Solid Tumors, Including Sarcomas

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • 1,3-BUTYLENE GLYCOL
    • Cinchocaine Hydrochloride
    • Irinotecan Hydrochloride Trihydrate
    France Italy The Netherlands Spain

  • Long-Term Safety Study of Iptacopan for Adults with IgA Nephropathy After Completing a Previous Study, Including ACE Inhibitors and ARBs Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • IgA nephropathy
    Investigated Drugs:
    • Ace Inhibitors, Plain
    • Angiotensin Ii Receptor Blockers (Arbs), Combinations
    • Angiotensin Ii Receptor Blockers (Arbs), Plain
    Belgium Czechia Denmark France Germany Hungary +7

  • Study Comparing Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone with Ciltacabtagene Autoleucel or Stem Cell Transplant for Newly Diagnosed Multiple Myeloma Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Ciltacabtagene Autoleucel
    • Bortezomib
    • Lenalidomide
    Belgium Czechia France Germany Greece The Netherlands +3

  • Study of LB-100 and Atezolizumab for Patients with Metastatic Colorectal Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • 3-(4-Methylpiperazine-1-Carbonyl)-7-Oxabiclo[2.2.1]Heptane-2-Carboxylic Acid
    • Atezolizumab
    The Netherlands

  • Study on Baricitinib and Anti-TNF Drug Combination for Patients with Rheumatoid Arthritis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Baricitinib
    • Etanercept
    • Adalimumab
    France

  • Study on Cangrelor and Bivalirudin for Patients with Heart Attack-Related Cardiogenic Shock or Cardiac Arrest on VA-ECMO Support

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cardiogenic shock
    Investigated Drugs:
    • Cangrelor Tetrasodium
    Italy
Previous Page
1 … 477 478 479 480 481 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!